I've been really sceptical of this business, largely because of TheDocYard's huge valuation and cash burn (and very little revenue and low-to-no revenue growth); and then combined business capitalising R&D in the 'Investing' part of the cash flows which when combined showed a quarterly burn...
...however, it looks like they have turned things around. The cash is finally starting to be positive, so looks promising! Well done to the Ansarada team.
I've been really sceptical of this business, largely because of...
Add AND (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.130(5.35%) |
Mkt cap ! $205.4M | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.44 | $2.28 | $1.908M | 800.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | $2.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.30 |
Change
-0.130 ( 5.35 %) |
||||
| Open | High | Low | Volume | ||
| $2.44 | $2.44 | $2.30 | 21137 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| AND (ASX) Chart |